Answers are grounded in this paper and cite their sources.
We extend the modified Gompertz hazard function, first used by Cantor and Shuster for estimation of cure rates from pediatric clinical trials, by including covariate effects. The extended model provides a convenient method for estimation of the cure rate as a function of treatments and covariates.
No takes yet. Share an insight, caveat, or question.
Gieser et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: